A Phase 2 Study of GW786034 (Pazopanib) in Asian Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2015
At a glance
- Drugs Pazopanib (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 16 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Sep 2007 Status changed from initiated to recruiting.
- 12 Jun 2007 New trial record.